Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;53(7):e14062.
doi: 10.1111/and.14062. Epub 2021 Apr 22.

Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review

José de Oliveira Vilar Neto  1   2 , Carlos Alberto da Silva  2 , Carlos Antônio Bruno da Silva  3 , Daniel V Pinto  1 , Juan de Sá Roriz Caminha  1 , Robson S de Matos  1 , Júlio C C Nunes Filho  1 , Felipe R Alves  1 , Saulo C Magalhães  4 , Elizabeth De Francesco Daher  1
Affiliations

Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review

José de Oliveira Vilar Neto et al. Andrologia. 2021 Aug.

Abstract

The anabolic-androgenic steroids (AAS) are clinically used as an androgen replacement, in hypogonadism treatment, to induce puberty, and also in the treatment of chronic degenerative diseases. The AAS use out of clinical context is becoming massively, being used merely for aesthetic reasons. AAS abuse may cause severe disarrangement on the HPG axis and generate a significant decrease in testosterone synthesis and secretion by the testes. This review aims to evaluate whether the hypogonadism induced by AAS abuse is reversible and under what circumstances the reversibility is possible. For this, PRISMA guidelines and several databases are used between July and September 2020. Altogether, this systematic review identified and analysed 179 cases of AAS users. Of these, 168 cases had the hypogonadism clearly diagnosed and proven to be linked exclusively to AAS abuse. However, between these 168 cases, only 38 cases presented fully known outcomes and among these, merely in 4, the hypogonadism was completely reversible (2 based on drug therapy) with HPG axis recovery. In conclusion, this review presents evidences that AAS-induced hypogonadism is a seriously underestimated problem, and in the majority of cases, full recovery is very difficult to succeed.

Keywords: AAS; anabolic-androgenic steroids; andrology; drug abuse; hypogonadism; hypothalamic-pituitary-gonadal axis.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Alibegovic, A. (2018). Testicular morphology in hypogonadotropic hypogonadism after the abuse of anabolic steroids. Forensic Science, Medicine and Pathology, 14(4), 564-567. https://doi.org/10.1007/s12024-018-0015-6
    1. Anawalt, B. D. (2019). Diagnosis and management of anabolic androgenic steroid use. Journal of Clinical Endocrinology and Metabolism, 104(7), 2490-2500. https://doi.org/10.1210/jc.2018-01882
    1. Bagatell, C. J., & Bremner, W. J. (1996). Androgens in men-uses and abuses. New England Journal of Medicine, 334(11), 707-714. https://doi.org/10.1056/nejm199603143341107
    1. Bagatell, C., & Bremner, W. J. (2003). Androgens in health and disease. Humana Press.
    1. Boettcher, M., Kosmehl, T., & Braunbeck, T. (2011). Low-dose effects and biphasic effect profiles: Is trenbolone a genotoxicant? Mutation Research, 723(2), 152-157. https://doi.org/10.1016/j.mrgentox.2011.04.012

Publication types